Fig. 5From: Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspectsDifferent mechanisms through which pioglitazone confers its actions in ADPKDBack to article page